Skip to main content
. Author manuscript; available in PMC: 2014 Oct 22.
Published in final edited form as: ACS Nano. 2013 Sep 12;7(10):10.1021/nn403281e. doi: 10.1021/nn403281e

Figure 5.

Figure 5

Design of a microfluidic channel for immunomagnetic capture, detection and characterization of CTCs (a). An example of distribution of captured COLO 205 cancer cells targeted with anti-EpCAM nanocarriers (b). Fluorescence and darkfield images of a captured COLO 205 cell (DAPI+/CK+/CD45−) and a white blood cell (DAPI+/CK−/CD45+); the cells were labeled using cytokeratin (CK), CD45 and DAPI stains (c).